-
1.
公开(公告)号:US20240101711A1
公开(公告)日:2024-03-28
申请号:US18516082
申请日:2023-11-21
Inventor: Hirohisa SAITO , Kenji MATSUMOTO , Hideaki MORITA , Go ICHIEN , Yasuhiko KOEZUKA , Kimishige ISHIZAKA
CPC classification number: C07K16/4291 , A61P37/08
Abstract: The disclosure provides a pharmaceutical composition containing an anti-IgE antibody that suppresses the production of allergen-specific IgE antibodies and methods of use thereof.
-
公开(公告)号:US20250163185A1
公开(公告)日:2025-05-22
申请号:US18516127
申请日:2023-11-21
Inventor: Hirohisa SAITO , Kenji MATSUMOTO , Hideaki MORITA , Go ICHIEN , Yasuhiko KOEZUKA , Kimishige ISHIZAKA
Abstract: The disclosure provides a pharmaceutical composition containing an anti-IgE antibody that suppresses the production of allergen-specific IgE antibodies and methods of use thereof
-
公开(公告)号:US20180214494A1
公开(公告)日:2018-08-02
申请号:US15881302
申请日:2018-01-26
Inventor: Yukihiro OHYA , Shigenori KABASHIMA , Osamu NATSUME , Hirohisa SAITO
CPC classification number: A61K35/57 , A61K9/0095 , A61K38/17 , A61P43/00
Abstract: The present invention provides an egg allergy prevention method to be carried out with respect to a human infant, including: a first administration period (first administration step) in which to administer, to an infant, heated egg white protein in an amount of 10 mg to 20 mg per day; and a second administration period (second administration step) which is a period after the first administration period and in which to administer, to the infant, the heated egg white protein in an amount of 65 mg to 90 mg per day.
-
-